ESB neyðist til að hefja rannsókn í Evrópu á 700% til 1600% aukningu á dauðsföllum á meðal barna þar sem EMA samþykkti COVID bóluefni fyrir börn
by The Expose
ESB neyðist til að hefja rannsókn í Evrópu á 700% til 1600% aukningu á dauðsföllum á meðal barna þar sem EMA samþykkti COVID bóluefni fyrir börn
Sérstök rannsókn sem teymið hér á The Exposé hefur framkvæmt hefur neytt opinbera tölfræðideild Evrópusambandsins til að hefja rannsókn um alla Evrópu á því hvers vegna veruleg aukning hefur orðið á óhóflegum dauðsföllum meðal barna á aldrinum 0 til 14 ára síðan Lyfjastofnun Evrópu samþykkti. Covid-19 sprautuna fyrir börn.
Þann 29. ágúst 2022 opinberuðum við eingöngu að opinberar tölur um dánartíðni í Evrópu sýndu átakanlega 691% aukningu á óhóflegum dauðsföllum meðal barna fram að 33. viku 2022 frá því að Lyfjastofnun Evrópu framlengdi leyfi til neyðarnotkunar Pfizer Covid-19 bóluefnisins. til notkunar fyrir börn á aldrinum 12 til 15 ára í maí 2021. Fyrir þessa ákvörðun Lyfjastofnunar Evrópu voru dauðsföll meðal barna árið 2021 undir væntanlegu hlutfalli.
En í kjölfar neyðarnotkunarheimildarinnar komumst við að því að óhófleg dauðsföll meðal barna höfðu aukist um mjög áhyggjuefni 1.599% í lok ársins miðað við meðaltal 2017 til 2020.. Nú, þremur vikum eftir rannsókn okkar, hefur EuroMOMO, sem útvegar tölfræðina, neyðst til að viðurkenna opinberlega aukna umframdánartíðni meðal barna og hefur hafið rannsókn um alla Evrópu á mögulegum orsökum. Við gerðum rannsókn okkar með því að nota gögnin sem EuroMOMO birti í viku 33, 2022 fréttablaðinu.
Hér er skyndimynd af fréttinni sem EuroMOMO gaf út á sínum tíma
Við gerðum rannsókn okkar með því að nota gögnin sem EuroMOMO birti í viku 33, 2022
VAERS COVID Vaccine Mortality Reports Through September 9, 2022
https://openvaers.com/covid-data/mortality
Saksóknari ESB opnar á rannsókn á bóluefnainnkaupum Evrópusambandsins
PPO skrifar í fréttatilkynningu:
„EPPO staðfestir að hafin er rannsókn á öflun covid-19 bóluefna til ESB. Þessi einstaka og sjaldgæfa staðfesting er gerð í kjölfar mikils áhuga almennings á málinu. Engar frekari upplýsingar verða gerðar opinberar á þessu stigi.“
Sagðist ætla að uppræta spillingu í eigin garði
Umboðsmaður ESB gagnrýndi Ursula von der Leyen í janúar, þegar starfsmenn hennar fylgdu ekki reglum framkvæmdastjórnar ESB um hreinskilni og gagnsæi í samningaviðræðum við Pfizer. Fólk sem tengist framkvæmdastjórn Evrópusambandsins er meðal annars sagt hafa hitt hagsmunaaðila, sem ekki voru á opinberri skrá ESB um samtök og fulltrúa, sem reyna að hafa áhrif á ákvarðanir innan ESB.
Formaður framkvæmdastjórnar ESB er einnig sagður hafa beitt „einka samningaviðræðum“ við öflun bóluefnasamninganna.
Margir hlutar samninganna eru leynilegir, þar á meðal upplýsingar um verðlagningu. Von der Leyen skrifaði á Twitter í september í ár:
„Ef við viljum vera trúverðug þegar við biðjum umsóknarríkin um að efla lýðræðisríki sín, þá verðum við líka að uppræta spillingu í eigin garði.“ Ekki er ljóst hvort von der Leyen sjálf sætir rannsókn vegna spillingar.
Eins og Útvarp Saga greindi nýlega frá, þá vakti hollenski ESB-þingmaðurinn Roob Roos spurninguna, hvort Pfizer bóluefnið hafi verið sannreynt að stöðva útbreiðslu smits áður en það var sett á markað. Fulltrúi Pfizer svaraði með hlátri og „nei“ og hafa viðbrögðin verið hörð um allan heim, sérstaklega á samfélagsmiðlum.
Albert Bourla, forstjóri Pfizer, átti upphaflega að máta hjá nefnd ESB-þingsins en hann dró sig úr á síðustu stundu og sendi þess í stað fulltrúa sinn. Franska ESB-þingkonan Virginie Joron krefst þess, að bæði Ursula von der Leyen og Albert Bourla geri grein undir eið fyrir því, hvernig stærstu kaup framkvæmdastjórnar ESB hafi í raun farið fram. Samkvæmt Epochtimes, þá sakar hún einnig Ursula von der Leyen um „meðvirka spillingu.“
The Exposé has forced the European Union’s official statistics department to begin a Europe-wide investigation into why there has been a significant increase in excess deaths among children aged 0 to 14 since the European Medicines Agency approved the Covid-19 injection for children.
On the 29th of August 2022, we exclusively revealed that official mortality figures for Europe showed a shocking 691% increase in excess deaths among children up to week 33 of 2022 since the European Medicines Agency extended the emergency use authorisation of the Pfizer Covid-19 vaccine for use in children aged 12 to 15 in May 2021.
Before this decision by the European Medicines Agency, deaths among children in 2021 were below the expected rate. But following the emergency use authorisation, we discovered that excess deaths among children had risen by a deeply troubling 1,599% by the end of the year compared to the 2017 to 2020 average.
Now, three weeks after our investigation, EuroMOMO, which provides the statistics, has been forced to officially acknowledge the elevated excess mortality among children and has opened a Europe-wide investigation into the possible causes.
We conducted our investigation using the data published by EuroMOMO in their week 33, 2022 bulletin.
Here’s a snapshot of the bulletin published by EuroMOMO at the time –
EuroMOMO failed to mention the elevated mortality among children aged 0 to 14.
However, three weeks on from our investigation they have been forced to do so as can be seen in a snapshot of EuroMOMO’s week 36 bulletin –
EuroMOMO also added a further note in its week 36 bulletin –
Upon realising that we have forced EuroMOMO to finally investigate why so many children are dying across Europe, we decided to revisit the official published data to find out how many more children had died between week 33 and week 36. But to our surprise and disgust, we discovered that EuroMOMO has now altered the baseline meaning all data on excess deaths from 2017 through to 2022 has been altered since our week 33 investigation.
The following is a snapshot of the data made available by EuroMOMO in week 36, and it shows 545 excess deaths among children aged 0 to 14 up to week 36 in 2022.
However, the following is a snapshot of the data made available by EuroMOMO in week 33, and it shows 841 excess deaths among children aged 0 to 14 up to week 33 in 2022.
This means EuroMOMO has now altered the baseline since our investigation to artificially reduce the severity of the number of excess deaths among children aged 0 to 14.
We are able to prove this thanks to the gift of the ‘WayBackMachine’ which is an Internet Archive of most pages available on the world wide web. The archived page showing the week 33 data can be viewed here.
Because of EuroMOMO’s extremely suspicious decision to alter the baseline at the same time as opening a Europe-wide investigation into the extraordinary rise in excess deaths among children since the European Medicine Agency’s decision to approve the Covid-19 vaccine for children, The Exposé will be urgently conducting another investigation into the rise in excess deaths based on the altered baseline.
But for now, you can read our original investigation in full below which has forced the European Union to conduct a Europe-wide investigation into why so many children are dying…
EuroMOMO is a European mortality monitoring activity. The organisation states that its aim is to “detect and measure excess deaths related to seasonal influenza, pandemics and other public health threats”.
Official national mortality statistics are provided weekly from the 29 European countries or subnational regions in the EuroMOMO collaborative network, supported by the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO), and hosted by Statens Serum Institut, Denmark.
The following chart shows the weekly excess deaths throughout 2020 and 2021 among children aged 0 to 14 across Europe. The graph has been taken from the EuroMOMO website and can be accessed here.
As you can see from the above, deaths among children throughout 2020 were generally below the expected number of deaths. This trend continued throughout 2021 up to week 22, at which point excess deaths were recorded week on week until the end of the year.
What’s interesting about the fact excess deaths began to be recorded among children in week 22 of 2021 is that it coincides with the week the European Medicines Agency (EMA) granted “an extension of indication for the COVID-19 vaccine Comirnaty (Pfizer) to include use in children aged 12 to 15″.
Just a few months later, the EMA also gave emergency use approval for the Pfizer vaccine to be administered to children as young as 5.
The following chart, extracted from the EuroMOMO website, shows the cumulative total number of excess deaths throughout both 2020 and 2021 from week 22 (the week the Covid-19 vaccine was approved for children) to week 52 (the end of the year).
According to EuroMOMO, Europe recorded 1,015 excess deaths among children during this time frame in 2021, whilst recording 491 fewer deaths than expected during this time frame in 2020.
The following chart shows the weekly excess deaths throughout 2022 among children aged 0 to 14 across Europe. The graph has been taken from the EuroMOMO website and can be accessed here.
The data so far covers up to week 33 of 2022 (mid-August), and as you can see the majority of weeks have seen deaths among children well above the expected rate. Week 24 saw a record 101 excess deaths among children aged 0 to 14.
The following chart, extracted from the EuroMOMO website, shows the cumulative total number of excess deaths throughout both 2022 up to week 33.
According to EuroMOMO, Europe recorded 841 excess deaths among children during this time frame compared to the expected rate.
Since the EMA first approved the Pfizer Covid-19 injection for use in children in May 2021, Europe has recorded 1,856 excess deaths among children aged 0 to 14 against the expected rate. This statistic alone is sickening because it represents an unbelievable 185,600% increase in deaths.
However, because that number is so unbelievably high it would be fairer to actually compare excess deaths among children post-Covid-19 vaccination against the average number of deaths among children in the previous few years.
The following chart shows the total number of excess deaths among children aged 0 to 14 in 2021 before EMA approval of the Covid-19 vaccine for 12 to 15-year-olds in week 22, compared to the same time frame in other years. The numbers have been extracted from the EuroMOMO website and can be accessed here.
The 2018 to 2020 average number of excess deaths among children across Europe between week 1 and week 21 equates to 191.3. But during the first 21 weeks of 2021, there were actually 198 fewer deaths among children than expected and 389.3 fewer deaths than the 2018 to 2020 average.
The following chart shows the total number of excess deaths among children aged 0 to 14 in 2021 following EMA approval of the Covid-19 vaccine for 12 to 15-year-olds in week 22, compared to the same time frame in other years. The numbers have been extracted from the EuroMOMO website and can be accessed here.
The 2017 to 2020 average number of excess deaths among children across Europe between week 22 and week 52 equates to 59.75. But during the same period in 2021, following EMA approval of the Pfizer Covid-19 vaccine for children, there were 1,015 more deaths among children than expected and 955.25 more deaths than the 2017 to 2020 average.
This means excess deaths among children throughout 2021 after EMA approval of the Covid-19 injection for children aged 12 to 15, increased by 1,599% compared to the 2017 to 2020 average.
The following chart shows the total number of excess deaths among children aged 0 to 14 in 2022 so far (Week 33) compared to the same time frame in other years. The numbers have been extracted from the EuroMOMO website and can be accessed here.
In 2022, children aged 5 and over across Europe have been offered the Covid-19 injection, and children aged 12 and over have been offered up to three doses of the Covid-19 injection.
The 2018 to 2021 average number of excess deaths among children between week 1 and week 33 equates to 175. But during the first 33 weeks of 2022, there were 841 more deaths among children than expected and 666 more deaths than the 2018 to 2021 average.
This means excess deaths among children throughout 2022 so far after EMA approval of the Covid-19 injection for children aged 5 and above, have increased by 381% compared to the 2018 to 2021 average.
Once we combine the figures for week 22 in 2021 onwards up to week 33 of 2022 (1,856 excess deaths), and compare them against the combined 2017 to 2020 & 2018 to 2021 average (234.75 excess deaths), we find that excess deaths among children across Europe have increased by 691% since the European Medicines Agency first approved a Covid-19 vaccine for children aged 12 to 15 in May 2021.
Is this just an unfortunate coincidence to add to the long list of “coincidences” that have occurred since early 2020? The authorities would most definitely like you to think so. But they still need to explain why thousands more children are dying than normally expected across Europe.
Um höfund
- ✞༺(((( Ⓒilla ℜągnąℜṧ )))༻♚༺ BA Classical Art Historian || MA Culture & Media || Tourism & Sales Management || Web Design || Photo & Videographer for Tourism Magasins ༻
Síðustu færslur
GLÆPUR GEGN MANNKYNI9. janúar, 2024Janet Ossebaard, höfundur heimildarmyndarinnar “The fall of the Cabal” fannst látin á jóladag
Sameinuðu Þjóðirnar28. desember, 2023Lestrarefni Menntamálastofnunar: Varúð hér býr vampíra – auðlesin sögubók á léttu máli og bókinni fylgir verkefnahefti sem hægt er að vinna samhliða lestri.
Heimsmarkmiðin27. desember, 2023Hin raunverulega merking og innhald 17 Heimsmarkmiða (UN) Sameinuðu þjóðanna
Óflokkað20. desember, 2023Hvað varð um Tinnu og hver er staða hennar í dag varðandi þá lömun sem hún varð fyrir neðan mitti eftir Moderna bólusetninguna?
